ArticleCell reports. Medicine2020

Development and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART Molecule.

Alexey Berezhnoy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.